跳至主要内容
临床试验/NCT04694638
NCT04694638已完成不适用

The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年5月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
6
试验地点
1
主要终点
Rate of intubation

研究概览

简要总结

This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 110 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with confirmed COVID19 infection or suspected COVID19 infection.
  • •Patients requiring HFNC or NIPPV
  • •Patients who are clinically stable and able to tolerate the changes in position that are routinely conducted as part of the standard of care in the medical ICU.
  • •Patient should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.
  • •Able to actively participate in Assisted Manual Pronation Therapy per nursing assessment.

排除标准

  • •Contraindication for prone positioning:
  • •Intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mmHg
  • •Massive hemoptysis requiring an immediate surgical or interventional radiology procedure
  • •Tracheal surgery or sternotomy during the previous 15 days
  • •Serious facial trauma or facial surgery during the previous 15 days
  • •Deep venous thrombosis treated for less than 2 days
  • •Cardiac pacemaker inserted in the last 2 days
  • •Unstable spine, femur, or pelvic fractures
  • •Hemodynamic instability or severe cardiac arrhythmia (chronic AFib is not a contraindication). Mean arterial pressure lower than 60 mm Hg, >1 vasopressor agent or Norepinephrine equivalent dose >0.06 mcg/kg/min
  • •Pregnant women
  • •Single anterior chest tube with air leaks
  • •Burns on more than 20 % of the body surface
  • •Delirium or altered mental status increasing fall risk while in prone position.
  • •End-of-life decision before inclusion
  • •Subject deprived of freedom, minor, subject under a legal protective measure
  • •Unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment
  • •Lacking capacity to provide informed consent.
  • •Individuals with mechanical or vascular disease precluding safe displacement of the head, for example: cervical spinal fusion, limited range of motion, or severe vascular occlusive disease of the head and neck.
  • •Body mass index (BMI) greater than 70 kg/m2, or unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment at any BMI value.

研究组 & 干预措施

HFNC and NIPPV

Experimental

Combined use of prone positioning and non-invasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC)

干预措施: Body position change (Other)

结局指标

主要结局

Rate of intubation

时间窗: 1 year

Number of critically ill patients with acute hypoxemic and/or hypercapnic respiratory failure, secondary to COVID-19 infection to require intubation and mechanical ventilation

次要结局

  • Incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gustavo A. Cortes Puentes

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验